IndiaTickerLatest filing: Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
ObservedCompany dossier
Aarti Pharma Labs
NSE:AARTIPHARM · ISIN INE0LRU01027
- Close
- ₹682.95 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aarti Pharma Labs
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹537.8 Cr · PAT ₹74 Cr.
Exchange XBRLLatest ownership: promoter group 42.86% and public 57.14% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
BSE · financial results
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aarti Pharmalabs Limited
NSE · exchange filing
Observed
Source filing Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Press Release - Aarti Pharmalabs Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹537.8 Cr
- Profit after tax
- ₹74 Cr
- EPS
- ₹8.16
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 42.86%
- Public
- 57.14%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL